Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$5.94 USD
-0.27 (-4.35%)
Updated Jul 17, 2024 04:00 PM ET
After-Market: $5.94 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth D Momentum C VGM
Aurora Cannabis Inc. (ACB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$5.70 | $8.03 | $3.67 | -8.21% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Aurora Cannabis Inc. comes to $5.70. The forecasts range from a low of $3.67 to a high of $8.03. The average price target represents a decline of 8.21% from the last closing price of $6.21.
Analyst Price Targets (5 )
Broker Rating
Aurora Cannabis Inc. currently has an average brokerage recommendation (ABR) of 2.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, one is Strong Buy, representing 16.67% of all recommendations. A month ago, Strong Buy represented 16.67%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ACB.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.67 | 2.67 | 2.67 | 2.67 | 2.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/25/2024 | Roth Capital Partners | William Kirk | Hold | Hold |
6/21/2024 | Canaccord Genuity | Matt Bottomley | Strong Buy | Strong Buy |
6/3/2024 | ATB Capital Markets | Frederico Gomes | Hold | Hold |
2/27/2024 | Not Identified | Not Identified | Hold | Hold |
2/21/2024 | CIBC World Markets Corp. | John Zamparo | Hold | Hold |
10/2/2023 | BMO Capital Markets | Tamy Chen | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.67 |
ABR (Last week) | 2.67 |
# of Recs in ABR | 6 |
Average Target Price | $5.70 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 102 of 252 |
Current Quarter EPS Est: | -0.19 |